REPERFUSION INJURY
Clinical trials for REPERFUSION INJURY explained in plain language.
Never miss a new study
Get alerted when new REPERFUSION INJURY trials appear
Sign up with your email to follow new studies for REPERFUSION INJURY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to limit heart damage after attack
Disease control Recruiting nowThis study tests a medicine called Xolatryp in adults who have had a severe type of heart attack (STEMI) and are getting a procedure to open the blocked artery. Participants receive either Xolatryp or a placebo as a one-time IV infusion over 6 hours. The study checks if the drug …
Matched conditions: REPERFUSION INJURY
Phase: PHASE2 • Sponsor: Nyrada Pty Ltd • Aim: Disease control
Last updated May 18, 2026 12:12 UTC
-
Chill out, heart attack: cooling arteries may reduce injury
Disease control Recruiting nowThis study tests a new way to reduce heart damage in people having a severe heart attack (STEMI). When blood flow is restored to the heart, it can cause additional injury. Researchers are cooling the heart's arteries during the procedure to see if this limits that damage. The tri…
Matched conditions: REPERFUSION INJURY
Phase: NA • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Disease control
Last updated May 18, 2026 12:03 UTC